Try
Tempus AI Inc. Class A Common Stock
TEMUnited States
10 filed reports · 378 financial concepts · 8 earnings calls · 9 media appearances
Filed reports
10 reports · Jun 2024 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 2 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 7 | 1,747 | Jun 2024 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 2 | 1,590 | Dec 2024 to Dec 2025 |
| Current · 8-KSEC EDGAR | 1 | 2 | Jun 2026 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Jul 30, 2026 | 433 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Jul 30, 2026 | 2 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 5, 2026 | 291 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 24, 2026 | 1,134 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 4, 2025 | 331 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 8, 2025 | 214 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 6, 2025 | 211 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 24, 2025 | 456 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 4, 2024 | 166 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 6, 2024 | 101 | Open |
Financial data
378 concepts · 3,339 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial374 concepts · 3,194 facts · Dec 2022 to Jun 2026
- Cash and cash equivalents at carrying value18 · Dec 2022 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents18 · Dec 2022 to Jun 2026
- Stockholders equity (US GAAP)18 · Dec 2022 to Jun 2026
- Allocated share based compensation expense17 · Dec 2022 to Jun 2026
- Comprehensive income net of tax17 · Dec 2022 to Jun 2026
- Cost of goods and services sold depreciation17 · Dec 2022 to Jun 2026
- Costs and expenses17 · Dec 2022 to Jun 2026
- Depreciation17 · Dec 2022 to Jun 2026
- Depreciation nonproduction17 · Dec 2022 to Jun 2026
- Goodwill impairment loss17 · Dec 2022 to Jun 2026
- Income loss from equity method investments17 · Dec 2022 to Jun 2026
- Interest expense debt17 · Dec 2022 to Jun 2026
- Investment income interest17 · Dec 2022 to Jun 2026
- Net income loss17 · Dec 2022 to Jun 2026
- Operating income loss17 · Dec 2022 to Jun 2026
- Other comprehensive income loss foreign currency transaction and translation adjustment net of tax17 · Dec 2022 to Jun 2026
- Other nonoperating income expense17 · Dec 2022 to Jun 2026
- Research and development expense17 · Dec 2022 to Jun 2026
- Revenue17 · Dec 2022 to Jun 2026
- Selling general and administrative expense17 · Dec 2022 to Jun 2026
- Technology research and development17 · Dec 2022 to Jun 2026
- Accretion expense16 · Dec 2022 to Jun 2026
- Accrued data licensing fees16 · Dec 2022 to Jun 2026
- Amortization of debt discount premium16 · Dec 2022 to Jun 2026
Product3 concepts · 143 facts · Dec 2022 to Jun 2026
- Revenue102 · Dec 2022 to Jun 2026
- Cost of goods and services sold (US GAAP)40 · Dec 2022 to Jun 2026
- Genomics Product1 · Dec 2023
Guidance1 concepts · 2 facts · Jul 2026
- Revenue Guidance2 · Jul 2026
Segments
143 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service10 members · 143 facts
- Data And Services26 · Dec 2022 to Sep 2025
- Genomic26 · Dec 2022 to Sep 2025
- Insights Product17 · Dec 2022 to Jun 2026
- Trials Product17 · Dec 2022 to Jun 2026
- Data And Applications14 · Dec 2023 to Jun 2026
- Diagnostics14 · Dec 2023 to Jun 2026
- Genomics Product14 · Dec 2022 to Sep 2025
- Data And Other8 · Jun 2023 to Sep 2025
- Next Product4 · Mar 2025 to Jun 2026
- AI Applications3 · Dec 2023 to Dec 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary112 claims from 10 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary47 claims from 6 reports · Sep 2024 to Dec 2025
- Risk-factor changes38 claims from 1 reports · Dec 2025
- Risk factors182 risks from 2 annual reports · 2024 to 2025
Earnings calls
8 calls · Nov 2024 to Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 30, 2026
- FY2026 Q1May 5, 2026
- FY2025 Q4Feb 24, 2026
- FY2025 Q3Nov 4, 2025
- FY2025 Q2Aug 8, 2025
- FY2025 Q1May 6, 2025
- FY2024 Q4Feb 24, 2025
- FY2024 Q3Nov 9, 2024
Executive media
9 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- Other appearances5 · Jul 2020 to Feb 2025
- Conference talks2 · Dec 2019 to Mar 2024
- TV interviews2 · Jun 2024 to Sep 2026
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.